mug10 Antibody

Shipped with Ice Packs
In Stock

Description

Potential Naming Confusion or Typographical Errors

The term "Mug1" (Murinoglobulin 1) appears in Search Result , describing a polyclonal antibody targeting mouse Murinoglobulin-1 (AA 700-910). Key characteristics include:

PropertyDetail
TargetMurinoglobulin 1 (Mug1)
Host SpeciesRabbit
ApplicationsELISA
Cross-ReactivityMouse-specific
Purification>95% purity via Protein G

If "mug10" is a typographical error for "Mug1," this antibody may represent the intended subject. Murinoglobulin-1 is a protease inhibitor involved in inflammatory responses and immune regulation.

Recommendations for Clarification

To resolve ambiguity, consider the following:

  • Verify the antibody name (e.g., "Mug1" vs. "mug10") with the original source or context.

  • Explore homologs: The term "mug" may refer to murinoglobulin family proteins, which have human homologs (e.g., α2-macroglobulin).

  • Expand search criteria: Broaden the scope to include antibodies targeting murinoglobulin-like domains or conserved epitopes.

IgM Antibodies

  • Structure: Pentameric/hexameric macro-immunoglobulins with high avidity for antigens .

  • Function: Neutralize pathogens, activate complement, and enhance mucosal immunity .

M8C10 Antibody

  • Target: Human metapneumovirus fusion protein (hMPV-F) .

  • Mechanism: Binds a conserved trimerization interface, blocking viral entry and egress .

  • Efficacy: Demonstrated 100% lung protection in cotton rat models at 15 mg/kg .

Anti-CTLA-4 (Ipilimumab)

  • Application: Checkpoint inhibitor for cancer immunotherapy .

  • Clinical Impact: Enhances T-cell responses in B-cell lymphoma and melanoma .

Research Gaps and Next Steps

To address the absence of "mug10 Antibody" in current literature:

  1. Database Searches: Query specialized repositories (e.g., UniProt, PubMed, Antibody Registry) for unpublished or proprietary antibodies.

  2. Commercial Catalogs: Review antibody vendors (e.g., Thermo Fisher, Vector Labs) for "mug10" listings.

  3. Technical Validation: If "mug10" is a novel target, initiate epitope mapping and hybridoma development.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
mug10 antibody; SPAC57A10.04 antibody; Meiotically up-regulated gene 10 protein antibody
Target Names
mug10
Uniprot No.

Target Background

Function
Plays a role in meiosis.
Database Links
Subcellular Location
Cytoplasm. Nucleus.

Q&A

What is MUG10 protein and why is it significant in research?

MUG10 (Meiotically up-regulated gene 10) protein is a 39,121 Da protein expressed in Schizosaccharomyces pombe during meiotic processes. The significance of this protein lies in its specific expression pattern during meiosis, making it an important marker for studying meiotic regulation in fission yeast. Understanding MUG10's role contributes to our broader knowledge of meiotic processes across eukaryotes and provides insights into fundamental cellular mechanisms of sexual reproduction. Research on MUG10 helps elucidate how gene expression is regulated during the transition from mitotic to meiotic cell division in model organisms .

What are the validated applications for MUG10 antibody?

MUG10 antibody has been validated for several research applications, primarily:

  • Western Blot (WB): For detecting MUG10 protein in cell lysates and evaluating expression levels

  • Enzyme-Linked Immunosorbent Assay (ELISA): For quantitative assessment of MUG10 protein

These applications enable researchers to investigate MUG10 expression patterns during different cellular states, particularly during meiosis in fission yeast. When designing experiments, researchers should consider that each application requires specific optimization parameters to ensure reliable results .

What controls should be included when using MUG10 antibody in experiments?

When designing experiments with MUG10 antibody, researchers should implement multiple controls to ensure data validity:

  • Positive control: Samples known to express MUG10 protein (e.g., S. pombe cells during meiosis)

  • Negative control: Samples where MUG10 expression is absent (e.g., mitotic cells or knockout strains)

  • Isotype control: Rabbit IgG at the same concentration to identify non-specific binding

  • Loading control: For Western blots, include detection of housekeeping proteins to normalize protein loading

  • Peptide competition: Pre-incubation of the antibody with immunizing peptide to confirm specificity

This systematic approach to controls helps distinguish specific signals from background noise and validates experimental findings, similar to control strategies employed with other research antibodies .

How should MUG10 antibody be stored and handled for optimal performance?

For maintaining antibody integrity and experimental reproducibility, MUG10 antibody requires specific storage and handling conditions:

  • Storage temperature: Store at -20°C or -80°C upon receipt

  • Avoid repeated freeze-thaw cycles (aliquot upon first thaw if possible)

  • Storage buffer composition: 50% Glycerol, 0.01M PBS (pH 7.4), 0.03% Proclin 300 as preservative

  • If small volumes become entrapped in the vial cap during shipping, briefly centrifuge before opening

  • Working dilutions should be prepared fresh before use

  • For long-term storage, maintain in the presence of a carrier protein (e.g., 0.1% BSA)

Proper storage and handling are essential for maintaining antibody activity and ensuring consistent experimental results across multiple studies .

How can epitope mapping be performed for MUG10 antibody?

Epitope mapping for MUG10 antibody can be approached through several advanced techniques:

  • Phage display technology:

    • Create a peptide library expressing fragments of the MUG10 protein

    • Perform 3-4 rounds of biopanning against the MUG10 antibody

    • Select and sequence 50-60 individual phage clones that bind to the antibody

    • Analyze common motifs among selected peptides to identify the epitope

  • Alanine scanning mutagenesis:

    • Generate a series of MUG10 protein variants with systematic alanine substitutions

    • Test antibody binding to each mutant

    • Identify critical residues required for antibody recognition

  • Hydrogen-deuterium exchange mass spectrometry (HDX-MS):

    • Compare exchange rates between free MUG10 protein and antibody-bound MUG10

    • Regions with reduced exchange when bound to antibody likely constitute the epitope

This approach has been successfully applied to other antibodies, such as mAb 10H10, where epitope mapping revealed the recognition of conserved regions in the target protein .

What strategies can be employed to optimize Western blot protocols for MUG10 antibody?

Optimizing Western blot protocols for MUG10 antibody requires systematic adjustment of multiple parameters:

ParameterOptimization StrategyRationale
Antibody dilutionTest range from 1:500 to 1:5000Balance between signal strength and background
Blocking agentCompare BSA vs. non-fat milk (3-5%)Different proteins block different non-specific interactions
Incubation timeTest 1h at room temperature vs. overnight at 4°CLonger incubation may increase sensitivity
Washing stringencyOptimize detergent concentration (0.05-0.3% Tween-20)Removes non-specific binding without disrupting specific interactions
Detection systemCompare ECL vs. fluorescent detectionDifferent sensitivities and dynamic ranges

Each parameter should be tested systematically while keeping others constant to identify optimal conditions. This approach ensures maximum sensitivity and specificity when detecting MUG10 protein in yeast samples, similar to optimization strategies used for other antibodies in research settings .

How can cross-reactivity of MUG10 antibody with related proteins be assessed?

Assessing cross-reactivity is crucial for ensuring experimental specificity. For MUG10 antibody, researchers should implement a multi-faceted approach:

  • Bioinformatic prediction:

    • Identify proteins with sequence similarity to MUG10 in S. pombe

    • Evaluate conservation of the epitope region in related proteins

    • Predict potential cross-reactive proteins using alignment tools

  • Experimental validation:

    • Test against recombinant proteins with sequence similarity to MUG10

    • Perform Western blots on MUG10 knockout/knockdown samples

    • Compare wild-type vs. mutant expression patterns

  • Immunoprecipitation-mass spectrometry:

    • Perform IP with MUG10 antibody followed by LC-MS/MS analysis

    • Identify all proteins pulled down by the antibody

    • Compare to predicted interactome to identify non-specific binding

This systematic approach helps distinguish between specific signal and potential artifacts, similar to methods used to validate antibody specificity in other research contexts .

What approaches can be used to study protein-protein interactions involving MUG10?

MUG10 protein interactions can be investigated using several complementary antibody-based techniques:

  • Co-immunoprecipitation (Co-IP):

    • Use MUG10 antibody to pull down the target protein and associated complexes

    • Identify interaction partners by Western blot or mass spectrometry

    • Compare interaction profiles under different cellular conditions (e.g., mitosis vs. meiosis)

  • Proximity Ligation Assay (PLA):

    • Use MUG10 antibody in combination with antibodies against suspected interaction partners

    • PLA produces fluorescent signals only when proteins are in close proximity (<40 nm)

    • Visualize interactions in their native cellular context

  • Bimolecular Fluorescence Complementation (BiFC):

    • Generate fusion proteins of MUG10 and potential partners with split fluorescent protein fragments

    • Use antibody to verify expression levels in parallel experiments

    • Fluorescence occurs only when proteins interact, bringing the fragments together

These methodologies provide complementary data about MUG10's interaction network, revealing both stable and transient interactions that may be functionally significant .

What are common sources of false positives/negatives when using MUG10 antibody?

Understanding potential artifacts is crucial for accurate data interpretation:

Error TypePossible CausesMitigation Strategies
False positivesNon-specific binding, cross-reactivity, secondary antibody issuesUse stringent washing, titrate antibody, include blocking peptide controls
False negativesEpitope masking, protein degradation, insufficient sensitivityTry multiple extraction methods, add protease inhibitors, use signal amplification
Inconsistent resultsBatch-to-batch variation, protocol inconsistenciesValidate each antibody lot, standardize protocols, maintain reference samples
Background issuesInsufficient blocking, high antibody concentrationOptimize blocking conditions, increase wash stringency, dilute antibody

Implementing these mitigation strategies helps ensure reliable and reproducible results when using MUG10 antibody, similar to quality control approaches used with other research antibodies .

How can MUG10 antibody be validated for immunofluorescence microscopy?

While MUG10 antibody is not specifically validated for immunofluorescence, researchers can establish this application through systematic optimization:

  • Fixation method optimization:

    • Compare paraformaldehyde (2-4%) vs. methanol fixation

    • Test different fixation durations (10-30 minutes)

    • Evaluate epitope preservation with each method

  • Permeabilization protocol:

    • Test different detergents (Triton X-100, saponin) at various concentrations

    • Optimize permeabilization time for balance between antibody access and structural preservation

    • Consider antigen retrieval methods if necessary

  • Antibody validation controls:

    • Include peptide competition controls

    • Compare staining pattern in known positive and negative samples

    • Correlate with GFP-tagged MUG10 expression pattern if available

  • Signal-to-noise optimization:

    • Test different antibody dilutions (1:100 to 1:1000)

    • Optimize blocking conditions and duration

    • Consider signal amplification systems for weak signals

This methodical approach helps establish reliable immunofluorescence protocols for studying MUG10 localization patterns during different stages of the yeast cell cycle .

How can post-translational modifications of MUG10 be studied using antibody-based methods?

Post-translational modifications (PTMs) of MUG10 can be investigated through several complementary approaches:

  • Immunoprecipitation-based strategies:

    • Use MUG10 antibody to immunoprecipitate the protein

    • Probe for specific modifications using PTM-specific antibodies (phospho, ubiquitin, etc.)

    • Analyze by mass spectrometry to identify all modifications present

  • 2D gel electrophoresis:

    • Separate proteins by isoelectric point and molecular weight

    • Detect MUG10 using the antibody via Western blot

    • Identify modified forms by altered migration patterns

  • Enzymatic treatments:

    • Treat samples with phosphatases, deglycosylation enzymes, etc., before Western blot

    • Compare migration patterns before and after treatment

    • Shifts in mobility indicate the presence of specific modifications

  • Phospho-specific analyses:

    • Use phospho-specific staining after IP with MUG10 antibody

    • Compare samples with and without phosphatase inhibitor treatment

    • Identify phosphorylation sites by mass spectrometry

These approaches provide insights into how PTMs regulate MUG10 function during different cellular processes in fission yeast .

What considerations are important when using MUG10 antibody for quantitative analysis?

For accurate quantitative analysis of MUG10 protein levels:

  • Standard curve establishment:

    • Use purified recombinant MUG10 protein at known concentrations

    • Generate standard curves under the same conditions as experimental samples

    • Ensure detection is within the linear range of the assay

  • Normalization strategies:

    • For Western blot: Normalize to housekeeping proteins (tubulin, actin)

    • For ELISA: Use total protein concentration for normalization

    • Consider spike-in controls for sample-to-sample comparison

  • Technical replication:

    • Perform at least three technical replicates per biological sample

    • Calculate coefficients of variation to ensure reliability

    • Establish acceptance criteria for technical variability

  • Statistical considerations:

    • Determine appropriate statistical tests based on data distribution

    • Account for multiple comparisons when analyzing across conditions

    • Report confidence intervals along with means/medians

Following these guidelines ensures that quantitative measurements of MUG10 are reproducible and statistically sound .

How can MUG10 antibody be used to study meiotic regulation in yeast models?

MUG10 antibody provides a valuable tool for investigating meiotic processes:

  • Temporal expression profiling:

    • Monitor MUG10 protein levels throughout meiotic progression via Western blot

    • Correlate expression with key meiotic events (DNA replication, recombination, division)

    • Compare with other meiotic markers to establish regulatory relationships

  • Chromatin association studies:

    • Perform chromatin immunoprecipitation (ChIP) for proteins that might regulate MUG10

    • Analyze enrichment at the MUG10 gene locus

    • Compare chromatin marks during mitosis vs. meiosis to identify regulatory mechanisms

  • Genetic interaction mapping:

    • Analyze MUG10 protein expression in various meiotic mutant backgrounds

    • Establish epistatic relationships between MUG10 and other meiotic regulators

    • Construct regulatory networks governing meiotic progression

  • Stress response analysis:

    • Investigate how environmental stressors affect MUG10 expression

    • Determine if MUG10 is involved in stress-responsive meiotic regulation

    • Compare normal and stress conditions to identify regulatory mechanisms

These approaches help establish MUG10's position in the complex regulatory network controlling meiosis in fission yeast .

What emerging technologies could enhance MUG10 antibody applications?

Several cutting-edge technologies offer new possibilities for MUG10 research:

  • Proximity labeling:

    • Generate MUG10 fusion proteins with BioID or APEX2

    • Use MUG10 antibody to confirm expression and localization

    • Identify proteins in close proximity to MUG10 in living cells

  • Super-resolution microscopy:

    • Apply STORM, PALM, or STED microscopy with MUG10 antibody

    • Achieve nanoscale resolution of MUG10 localization

    • Correlate with other cellular structures beyond diffraction limit

  • Single-cell proteomics:

    • Use mass cytometry (CyTOF) with metal-conjugated MUG10 antibody

    • Correlate MUG10 expression with dozens of other proteins at single-cell resolution

    • Identify cell subpopulations with distinct MUG10 expression patterns

  • Antibody engineering:

    • Develop recombinant antibody fragments (Fab, scFv) against MUG10

    • Create bispecific antibodies to study MUG10 in complex with other proteins

    • Engineer antibodies with enhanced properties for specific applications

These emerging technologies will provide unprecedented insights into MUG10 function, regulation, and interactions in fission yeast cells .

How can MUG10 antibody be integrated with genomic and transcriptomic approaches?

Integration of antibody-based protein detection with genomic and transcriptomic data provides a comprehensive understanding of MUG10 biology:

  • ChIP-seq integration:

    • Perform ChIP-seq for transcription factors binding to MUG10 promoter

    • Correlate binding patterns with protein expression detected by antibody

    • Identify regulatory elements controlling MUG10 expression

  • RNA-seq correlation:

    • Compare MUG10 mRNA levels (RNA-seq) with protein levels (Western blot)

    • Identify potential post-transcriptional regulation

    • Analyze correlation patterns across different cellular conditions

  • CRISPR screening validation:

    • Perform CRISPR screens to identify regulators of MUG10

    • Validate hits using MUG10 antibody to confirm protein-level effects

    • Distinguish transcriptional vs. post-transcriptional regulation

  • Multi-omics data integration:

    • Combine proteomics, transcriptomics, and genomics data

    • Create integrated regulatory models of MUG10 expression

    • Validate predictions using targeted experiments with MUG10 antibody

This multi-layered approach provides a systems-level understanding of MUG10 regulation and function in cellular processes .

How does MUG10 protein function compare across different yeast species?

Comparative analysis of MUG10 across species provides evolutionary insights:

  • Cross-species reactivity testing:

    • Evaluate MUG10 antibody reactivity with homologs in related yeast species

    • Determine epitope conservation through sequence alignment

    • Test antibody on lysates from multiple yeast species

  • Functional conservation analysis:

    • Compare expression patterns of MUG10 homologs during meiosis

    • Analyze phenotypes of MUG10 mutations across species

    • Use antibody to track protein expression in complementation studies

  • Structural comparison:

    • Predict protein structures of MUG10 homologs

    • Identify conserved domains that might be recognized by the antibody

    • Correlate structural features with functional conservation

  • Heterologous expression studies:

    • Express MUG10 homologs from different species in S. pombe

    • Use antibody to detect expression levels and localization

    • Determine functional complementation across species

This evolutionary perspective helps identify conserved aspects of MUG10 function that are likely to be fundamental to meiotic processes across fungi .

What comprehensive experimental design is recommended for studying MUG10 expression during meiosis?

A robust experimental design for studying MUG10 during meiosis should include:

  • Synchronization protocol optimization:

    • Test different methods for synchronizing cells at meiotic entry

    • Validate synchrony using established meiotic markers

    • Collect samples at defined timepoints throughout meiotic progression

  • Multi-level analysis platform:

    • Protein level: Western blot with MUG10 antibody

    • Transcript level: RT-qPCR or RNA-seq for MUG10 mRNA

    • Genetic level: Reporter constructs to track promoter activity

  • Control samples:

    • Positive controls: Strains overexpressing MUG10

    • Negative controls: MUG10 deletion strains

    • Comparative controls: Strains with tagged MUG10 (GFP, FLAG, etc.)

  • Perturbation experiments:

    • Chemical inhibitors of meiotic processes

    • Genetic mutations in meiotic regulatory pathways

    • Environmental stress conditions that affect meiosis

This comprehensive approach ensures reliable characterization of MUG10 expression patterns and regulatory mechanisms during meiosis .

How can reproducibility be ensured when using MUG10 antibody across different studies?

Ensuring reproducibility requires standardization of multiple experimental parameters:

  • Antibody validation documentation:

    • Record lot number and source of antibody

    • Document validation experiments performed (specificity, sensitivity)

    • Maintain reference samples for cross-batch comparison

  • Detailed protocol documentation:

    • Record all buffer compositions precisely

    • Document incubation times, temperatures, and washing procedures

    • Specify equipment settings (exposure times, gain settings, etc.)

  • Quantification standards:

    • Include calibration samples in each experiment

    • Use consistent quantification methods across studies

    • Report raw data alongside normalized results

  • Metadata reporting:

    • Document strain backgrounds and genetic modifications

    • Record growth conditions and media compositions

    • Note any deviations from standard protocols

Adherence to these practices enables meaningful comparison of results across different studies and laboratories, enhancing the collective knowledge about MUG10 biology .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.